---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-002892"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:17:30.496216+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv reports Q1 revenue of $2.5M, near breakeven net income

## Summary
- Revenue for quarter ended Jan 31, 2025 was ~$2.5M, up ~$0.1M YoY.
- Net income near breakeven, an increase of ~$0.3M compared to same quarter last year.
- CEO cites net revenue growth in served markets with projects in Europe, Asia, and Latin America.

## SEC filing metadata
- accession: 0001654954-25-002892
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495425002892/0001654954-25-002892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495425002892/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-002892
- JSON: https://secwatch.observer/filing/0001654954-25-002892.json
- Plain text: https://secwatch.observer/filing/0001654954-25-002892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.